CA2129013C - Pyridinecarboximidamide compounds and the use thereof - Google Patents

Pyridinecarboximidamide compounds and the use thereof Download PDF

Info

Publication number
CA2129013C
CA2129013C CA002129013A CA2129013A CA2129013C CA 2129013 C CA2129013 C CA 2129013C CA 002129013 A CA002129013 A CA 002129013A CA 2129013 A CA2129013 A CA 2129013A CA 2129013 C CA2129013 C CA 2129013C
Authority
CA
Canada
Prior art keywords
pyridinecarboximidamide
cyano
amino
chlorophenyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002129013A
Other languages
English (en)
French (fr)
Other versions
CA2129013A1 (en
Inventor
Hideki Okawara
Tatsuo Nakajima
Nobuyuki Ogawa
Tomoko Kashiwabara
Soichiro Kaneta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Publication of CA2129013A1 publication Critical patent/CA2129013A1/en
Application granted granted Critical
Publication of CA2129013C publication Critical patent/CA2129013C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002129013A 1992-01-28 1993-01-28 Pyridinecarboximidamide compounds and the use thereof Expired - Fee Related CA2129013C (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP1334292 1992-01-28
JP13342/1992 1992-01-28
JP6622192 1992-03-24
JP66221/1992 1992-03-24
JP32576092 1992-12-04
JP325760/1992 1992-12-04
PCT/JP1993/000103 WO1993015057A1 (en) 1992-01-28 1993-01-28 Pyridinecarboximidamide compound and use thereof

Publications (2)

Publication Number Publication Date
CA2129013A1 CA2129013A1 (en) 1993-07-29
CA2129013C true CA2129013C (en) 2001-08-14

Family

ID=27280214

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002129013A Expired - Fee Related CA2129013C (en) 1992-01-28 1993-01-28 Pyridinecarboximidamide compounds and the use thereof

Country Status (18)

Country Link
US (1) US5508293A (fi)
EP (1) EP0634400B1 (fi)
JP (1) JP2648395B2 (fi)
KR (1) KR100249755B1 (fi)
CN (1) CN1043760C (fi)
AT (1) ATE151073T1 (fi)
AU (1) AU674839B2 (fi)
CA (1) CA2129013C (fi)
DE (1) DE69309454T2 (fi)
DK (1) DK0634400T3 (fi)
ES (1) ES2100522T3 (fi)
FI (1) FI105399B (fi)
HK (1) HK1000094A1 (fi)
HU (1) HU218487B (fi)
MX (1) MX9300433A (fi)
NO (1) NO302070B1 (fi)
TW (1) TW232009B (fi)
WO (1) WO1993015057A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
WO1997000239A1 (fr) * 1995-06-14 1997-01-03 Sankyo Company, Limited Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
WO1998035673A1 (fr) * 1997-02-14 1998-08-20 Kirin Beer Kabushiki Kaisha Medicaments utilises dans la decongestion du flux sanguin peripherique
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
JP2003321329A (ja) * 2002-04-25 2003-11-11 Kirin Brewery Co Ltd 育毛剤
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
WO2004080283A2 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
TW200908984A (en) 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EP3088390A1 (en) 2015-04-30 2016-11-02 Bayer CropScience AG Catalytic hydrogenation of substituted cyanopyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95244C (fi) * 1988-12-27 1996-01-10 Kirin Brewery Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja
JPH0662567B2 (ja) * 1988-12-27 1994-08-17 麒麟麦酒株式会社 ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
JP2846070B2 (ja) * 1989-11-29 1999-01-13 麒麟麦酒株式会社 カルボキシイミダミド誘導体

Also Published As

Publication number Publication date
NO942740D0 (no) 1994-07-22
DK0634400T3 (da) 1997-04-28
HUT70506A (en) 1995-10-30
AU674839B2 (en) 1997-01-16
HK1000094A1 (en) 1997-11-21
KR950700255A (ko) 1995-01-16
MX9300433A (es) 1994-07-29
EP0634400A4 (en) 1995-06-14
FI943508A (fi) 1994-09-22
HU218487B (hu) 2000-09-28
KR100249755B1 (ko) 2000-04-01
NO942740L (no) 1994-09-27
US5508293A (en) 1996-04-16
EP0634400B1 (en) 1997-04-02
CN1077949A (zh) 1993-11-03
ES2100522T3 (es) 1997-06-16
DE69309454D1 (de) 1997-05-07
WO1993015057A1 (en) 1993-08-05
NO302070B1 (no) 1998-01-19
ATE151073T1 (de) 1997-04-15
CN1043760C (zh) 1999-06-23
EP0634400A1 (en) 1995-01-18
FI105399B (fi) 2000-08-15
AU3367793A (en) 1993-09-01
HU9402218D0 (en) 1994-09-28
TW232009B (fi) 1994-10-11
FI943508A0 (fi) 1994-07-26
CA2129013A1 (en) 1993-07-29
JP2648395B2 (ja) 1997-08-27
DE69309454T2 (de) 1997-08-14

Similar Documents

Publication Publication Date Title
CA2129013C (en) Pyridinecarboximidamide compounds and the use thereof
RU2195453C2 (ru) Цианогуанидины, способы их получения и фармацевтический препарат на их основе
US5464849A (en) N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
US5948816A (en) 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
JP2895913B2 (ja) ブテン酸誘導体
NZ501266A (en) Cyanoguanidines as cell proliferation inhibitors
JPH0662567B2 (ja) ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
JP3690831B2 (ja) インドール含有スルホンアミド誘導体
JP3712529B2 (ja) 3,3−ジピリジルアクリル酸アミド誘導体又はその薬学的に許容される塩
WO2008142623A2 (en) Tumor necrosis factor - alpha inhibitors
SG189146A1 (en) 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer
HU180617B (en) Process for producing 1,2-bis-bracket-nicotinamido-bracket closed-propane,salts and pharmaceutical compositions containing them
JPH09176165A (ja) イミダゾ[1,2−a]ピリジン誘導体、その製法およびその用途
EP0210581B1 (en) 1,4-benzodioxane derivatives, process for preparing them, pharmacological composition and use
JP2535528B2 (ja) 〔2−(1,3−ベンゾジオキソ−ル−5−イル)エチル〕チオ誘導体
JPH0635458B2 (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
AU628485B2 (en) P-aminophenol derivative and production and application thereof
KR970005907B1 (ko) 신규한 카르복시이미다미드 유도체 및 그의 제조방법
EP0257918A1 (en) Quinolone cardiac stimulants
JPS6134424B2 (fi)
JP2802778B2 (ja) ホモピペラジン誘導体及びこれを含有する脳保護剤
US6028068A (en) Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
NZ253753A (en) Triazene derivatives of pyrimidine and pharmaceutical compositions
JP2794637B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP2777146B2 (ja) ベンゾジオキソール誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed